IRICoR is a not-for-profit drug discovery and commercialization centre based at the Institute for Research in Immunology and Cancer (IRIC) on the Université de Montréal campus. Our main objective is to rapidly translate highly innovative scientific projects into high value novel therapies in oncology, immunology, and related indications through strong partnerships with the private sector — thereby efficiently bridging the innovation translation gap between early stage academic research and industry.